Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells
- PMID: 12351642
- DOI: 10.1074/jbc.M208192200
Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells
Abstract
The alpha-synuclein fibrillation process has been associated with the pathogenesis of several neurodegenerative diseases. Here, we have characterized the cytoplasmic alpha-synuclein aggregates using a fractionation procedure with which different aggregate species can be separated. Overexpression of alpha-synuclein in cells produce two distinct types of aggregates: large juxtanuclear inclusion bodies and small punctate aggregates scattered throughout the cytoplasm. Biochemical fractionation results in an inclusion-enriched fraction and two small aggregate fractions. Electron microscopy and thioflavin S reactivity of the fractions show that the juxtanuclear inclusion bodies are filled with amyloid-like alpha-synuclein fibrils, whereas both the small aggregate fractions contain non-fibrillar spherical aggregates with distinct size distributions. These aggregates appear sequentially, with the smallest population appearing the earliest and the fibrillar inclusions the latest. Based on the structural and kinetic properties, we suggest that the small spherical aggregates are the cellular equivalents of the protofibrils. The proteins that co-exist in the Lewy bodies, such as proteasome subunit, ubiquitin, and hsp70 chaperone, are present in the fibrillar inclusions but absent in the protofibrils, suggesting that these proteins may not be directly involved in the early aggregation stage. As predicted in the aggresome model, disruption of microtubules with nocodazole reduced the number of inclusions and increased the size of the protofibrils. Despite the increased size, the protofibrils remained non-fibrillar, suggesting that the deposition of the protofibrils in the juxtanuclear region is important in fibril formation. This study provides evidence that the cellular fibrillation also involves non-fibrillar intermediate species, and the microtubule-dependent inclusion-forming process is required for the protofibril-to-fibril conversion in cells.
Similar articles
-
Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion.J Biol Chem. 2002 Dec 13;277(50):48984-92. doi: 10.1074/jbc.M208194200. Epub 2002 Sep 25. J Biol Chem. 2002. PMID: 12351643
-
Molecular crowding accelerates fibrillization of alpha-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease?Biochemistry. 2002 Mar 26;41(12):3855-60. doi: 10.1021/bi0120906. Biochemistry. 2002. PMID: 11900526
-
Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors.J Biol Chem. 2002 Feb 15;277(7):5411-7. doi: 10.1074/jbc.M105326200. Epub 2001 Nov 27. J Biol Chem. 2002. PMID: 11724769
-
Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease.Biochemistry. 2003 Jul 8;42(26):7871-8. doi: 10.1021/bi030086j. Biochemistry. 2003. PMID: 12834338 Review.
-
[Alpha-synucleinopathies].Neurologia. 2001 Apr;16(4):163-70. Neurologia. 2001. PMID: 11412709 Review. Spanish.
Cited by
-
Imaging nanometer-sized α-synuclein aggregates by superresolution fluorescence localization microscopy.Biophys J. 2012 Apr 4;102(7):1598-607. doi: 10.1016/j.bpj.2012.03.010. Epub 2012 Apr 3. Biophys J. 2012. PMID: 22500760 Free PMC article.
-
Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia.Nat Commun. 2013;4:1562. doi: 10.1038/ncomms2534. Nat Commun. 2013. PMID: 23463005 Free PMC article.
-
Protein misfolding specifies recruitment to cytoplasmic inclusion bodies.J Cell Biol. 2016 Apr 25;213(2):229-41. doi: 10.1083/jcb.201511024. J Cell Biol. 2016. PMID: 27114501 Free PMC article.
-
The vermiform appendix impacts the risk of developing Parkinson's disease.Sci Transl Med. 2018 Oct 31;10(465):eaar5280. doi: 10.1126/scitranslmed.aar5280. Sci Transl Med. 2018. PMID: 30381408 Free PMC article.
-
An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels.Mol Neurobiol. 2022 Jan;59(1):620-642. doi: 10.1007/s12035-021-02596-3. Epub 2021 Nov 8. Mol Neurobiol. 2022. PMID: 34750787 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous